Discontinuation report ENGERIX-B

Last updated on 2020-04-30 History
Report ID 100907
Drug Identification Number 02296454
Brand name ENGERIX-B
Common or Proper name Hepatitis B vaccine (recombinant)
Company Name GLAXOSMITHKLINE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 10MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's (Vial / Fiole)
ATC code J07BC
ATC description VIRAL VACCINES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-04-30
Actual discontinuation date 2020-04-24
Remaining supply date 2021-04-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments This pack size has been discontinued.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2020-04-30 French Compare
v11 2020-04-30 English Compare
v10 2020-03-31 French Compare
v9 2020-03-31 English Compare
v8 2020-03-31 French Compare
v7 2020-03-31 English Compare
v6 2020-02-28 French Compare
v5 2020-02-28 English Compare
v4 2020-01-17 French Compare
v3 2020-01-17 English Compare
v2 2019-12-10 French Compare
v1 2019-12-10 English Compare

Showing 1 to 12 of 12